Armenia vs Norway: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Norway
100.0%
in 2024
Armenia rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Norway
How they compare
Armenia currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 6 times across 20 shared years of data; in 2005 it was Norway ahead.
Armenia ranks 1st and Norway ranks 1st of 180 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Armenia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.4% | 60.0% | 15.6% | Norway |
| 2010s | 39.7% | 62.5% | 22.8% | Norway |
| 2020s | 98.4% | 89.4% | 9.0% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Norway?
- Armenia, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Norway?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Norway?
- 20 years are reported by both, from 2005 to 2024.
- How do Armenia and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.